Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 760-766

  Yi, Geng Hua ^a   Burkhoff, Daniel ^a   Zhang, Hui ^a   Zhu, Shu Ming ^a   Zwas, Donna ^a   Wang, Jie ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 CYANO 6 METHYL 4 (3 PHENYL 5 QUINOLINYL) 3 PYRIDINECARBOXYLIC ACID ISOPROPYL ESTER; CALCIUM CHANNEL AFFECTING AGENT; DIHYDROPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HEMODYNAMIC MONITORING; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CALCIUM CHANNEL AGONISTS; DIHYDROPYRIDINES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; TIME FACTORS;

EID: 0032440305     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bechem M, Goldmann S, Gross R, Hallermann S, Hebisch S, Hutter J, Rounding HP, Schramm M, Stoltefuss J and Straub A (1997) A new type of Ca-channel modulation by a novel class of 1, 4-dihydropyridines. Life Sci 60:107-118.
2. Brooks VL, Ell KR and Wright RM (1993) Pressure-independent baroreflex resetting produced by chronic infusion of angiotensin II in rabbits. Am J Physiol 265: H1275-H1282.
3. Brown AM, Kunze DL and Tatani A (1986) The agonist effect of dihydropyridines on Ca channels. Nature (Lond) 311:570-572.
4. Dembowsky K, Jahnel U, Lohrmann E, Stoltefuss J and Gross R (1996) Modulation of the beating frequency of cardiomyocytes in vitro by various calcium channel activators (Abstract). Circulation 94:I-556.
5. Fritsch JM, Rea RF and Eckberg DL (1989) Carotid baroreflex resetting during drug-induced arterial pressure changes in humans. Am J Physiol 256:R549-R553.
6. Hajjar RJ and Gwathmey JK (1992) Cross-bridge dynamics in human ventricular myocardium. Regulation of contractability in the failing heart. Circulation 86: 1819-1826.
7. Head GA (1995) Baroreflexes and cardiovascular regulation in hypertension. J Cardiovasc Pharmacol 26:suppl 2,S7-S16.
8. Heesch CM, Crandall ME and Turbek JA (1996) Converting enzyme inhibitors cause pressure-independent resetting of baroreflex control of sympathetic outflow. Am J Physiol 270:R728-R737.
9. Hess P, Lansman JB and Tsien RW (1986) Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Naure (Lond) 311:538-544.
10. Huetter J, Bechem M, Goldmann S, Gross R, Hebisch S, Rounding P, Schramm M, Stoltefuss J and Straub A (1994) Haemodynamic actions of the novel positive inotropic dihydropyridine BAY y 5959 in anaesthetized and conscious dogs [Abstract]. Eur Heart J 15:202.
11. Ishii K, Sato Y and Taira N (1986) Similarity and dissimilarity of the vasoconstrictor effects of BAY k 6844 on coronary, femoral, mesenteric and renal circulations in dogs. Br J Pharmac 88:369-377.
12. Knecht M, Burkhoff D, Yi GH, Popilskis S, Homma S, Packer M and Wang J (1997) Coronary endothelial dysfunction precedes heart failure and reduction of coronary reserve in awake dogs. J Mol Cell Cardiol 29:217-227.
13. Pagel PS, Hettrick DA and Warltier DC (1994) Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs. Anesthesiology 81:190-208.
14. Qian ZM, Xiao DS, Huang WQ, Tang PL and Xu B (1997) Central ANG II receptor involved in carotid sinus reflex resetting in chronically stressed rats. Physiol Behav 62:241-247.
15. Rousseau MF, Massart PE, Van Eyll C, Etienne J, Ahn S, Schaefer HG, Mueck W, Mornemann M and Pouleur H (1997) Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure. J Am Coll Cardiol 30:1751-1757.
16. Rump AFE, Rosen R, Sigmund B, Fuchs J and Klaus W (1992) Studies on the influence of Bay K 8644 on hemodynamics and the size of a regional ischemia in isolated rabbit hearts. J Moll Cell Cardiol 24:suppl. V,85.
17. Rump AFE, Rosen R, Sigmund B, Fuchs J, Ratke R and Klaus W (1993) Influence of dihydropyridine-type calcium agonists on hemodynamics and myocardial ischemia in isolated rabbit hearts. Drug Res 43:1056-1059.
18. Sato N, Uechi M, Asai K, Patrick T, Kudej RK and Vatner SF (1997) Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: Comparison with dobutamine and milrinone. Am J Physiol 272(HCP41):H753-H759.
19. 2+ channels. Nature (Lond) 303:535-537.
20. Todaka K, Wang J, Yi G-H, Gu A, Zhu S-M, Zhang H and Burkhoff D (1998) Effect of BAY y 5959 on myocardial function and metabolism in normal and failing hearts. Am J Physiol 274(HCP43):H1560-H1568.
21. Uechi M, Sato N, Kudej RK and Vatner SF (1995) Effects of a voltage-dependent calcium channel agonist on left ventricular function and baroreflex sensitivity in conscious dogs with heart failure. Circulation 92:I-654.